Global Liver Institute

October 13, 2021

The GLI LIVE episode with Dr. Sharpless is the first #OctoberIs4Livers activity in a series of engaging and informative global activities taking place throughout the month of October to raise awareness about liver cancer and address the many disparities that exist with this disease.

August 13, 2021

Global Liver Institute (GLI) CEO and President Donna R. Cryer, JD, today applauded dual actions from U.S. government health agencies.

May 16, 2021

Few liver health advocacy organizations have policy staff or personnel in Washington, DC. To fill this gap, we provide liver health policy updates to report on timely information and actionable updates on activities relevant to liver health, including liver cancer, viral hepatitis, autoimmune liver conditions as well as issues that span conditions, such as coverage or other policy decisions.

May 09, 2021

The COVID-19 Response Program for Patients features information tailored to the special needs of patients living with pediatric liver disease, rare liver disease, NASH, pre/post liver transplant and liver cancer.

November 16, 2020

The Congressionally Directed Medical Research Programs’ (CDMRP), Peer Reviewed Cancer Research Program (PRCRP) consumer advocate Steven West recently participated in the evaluation of research applications submitted to the PRCRP.

April 20, 2020

The COVID-19 Response Program for Patients features information tailored to the special needs of patients living with pediatric liver disease, rare liver disease, NASH, pre & post liver transplant, and liver cancer.

October 26, 2017

A free two-day workshop will train people who want to raise awareness of liver diseases and influence public health policy to address their concerns.

August 21, 2017

Donna Cryer, CEO and president of the Global Liver Institute, discusses the importance of having diverse clinical trials in cancer care.